QLT Inc. (T.QLT) hit a new 52-week high of $6.00; QLT Inc. today announced interim results from the first three subjects enrolled in a Phase 1b clinical proof-of-concept study of QLT091001 in the treatment of Leber congenital amaurosis (LCA), an inherited progressive retinal degenerative disease that leads to retinal dysfunction and significant visual impairment beginning at birth. QLT091001 is an orally administered synthetic retinoid replacement for 11-cis-retinal, which is a key biochemical component of visual function.
Canadian Pacific Railway Limited (T.CP) hit a new 52-week high of $59.98; no news announcements today
Goodfellow Inc. (T.GDL) hit a new 52-week high of $11.80; no news announcements today
Enbridge Inc. (T.ENB) hit a new 52-week high of $50.99; no news announcements today
Canadian National Railway Company (T.CNR) hit a new 52-week high of $63.84; no news announcements today
Cardiome Pharma Corp. (T.COM) hit a new 52-week high of $8.68; no news announcements today
Western Coal Corp. (T.WTN) hit a new 52-week high of $6.97; no news announcements today
New Gold Inc. (T.NGD) hit a new 52-week high of $5.39; no news announcements today
Andean Resources Limited (T.AND) hit a new 52-week high of $3.24; no news announcements today
Gennum Corporation (T.GND) hit a new 52-week high of $7.80; no news announcements today
Related Stories
